Evogene

EVGN • NASDAQ • Stock Fundamentals

Evogene is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ofer Haviv, with a market cap of $7.4M.

Market Cap$7.4M

Employees143.0

CEOOfer Haviv

CountryIsrael

Healthcare

Biotechnology

Most Recent EarningsMay 20, 2026 · 8 days agoQ1 2026

Next EarningsAug 26, 2026 · in 3 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Evogene

Evogene (EVGN) has a market capitalization of $7.4M and trades on NASDAQ.

Evogene has approximately 143 employees.